Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis

Clinical trial NCT06510283 · RECRUITING

Trial details

NCT number: NCT06510283
Sponsor: Beijing Tongren Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Start date: 2024-12-01
Primary completion: 2027-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.